Literature DB >> 9596387

Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions.

P Denys1, M Mane, P Azouvi, E Chartier-Kastler, J B Thiebaut, B Bussel.   

Abstract

OBJECTIVE: Assess modifications of sexual function in men treated with intrathecal baclofen for spinal spasticity.
DESIGN: Prospective before-after trial.
SETTING: A rehabilitation department of a university hospital; follow-up was on an outpatient basis. PATIENTS: A convenience sample of nine consecutively recruited men with spinal cord injury or multiple sclerosis who were receiving intrathecal baclofen by an implantable pump; average follow-up was 44.4 months. MAIN OUTCOME MEASURES: A questionnaire focusing on: libido; ability to sustain reflexive and psychogenic erections; rigidity, evaluated by a visual analog scale; maximum duration of erection; possibility of ejaculation.
RESULTS: Libido and the ability to obtain psychogenic or reflexogenic erections were not modified. However, eight patients reported a decrease of erection rigidity and/or duration. Ejaculation was possible in three cases before implantation. It disappeared in two patients, and was more difficult to obtain in the last one. It reappeared after treatment withdrawal. No differences were found between multiple sclerosis and spinal cord injured patients.
CONCLUSION: Intrathecal baclofen may compromise erection and ejaculation. This effect is reversible. Patients should be informed of this effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596387     DOI: 10.1016/s0003-9993(98)90061-2

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  8 in total

Review 1.  Recent advances in the medical and surgical treatment of priapism.

Authors:  Adam Shrewsberry; Aaron Weiss; Chad W M Ritenour
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

2.  Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues.

Authors:  Kimberly A Young; Teresa R Franklin; David C S Roberts; Kanchana Jagannathan; Jesse J Suh; Reagan R Wetherill; Ze Wang; Kyle M Kampman; Charles P O'Brien; Anna Rose Childress
Journal:  J Neurosci       Date:  2014-04-02       Impact factor: 6.167

Review 3.  Medical management of ischemic stuttering priapism: a contemporary review of the literature.

Authors:  Helen R Levey; Omer Kutlu; Trinity J Bivalacqua
Journal:  Asian J Androl       Date:  2011-11-07       Impact factor: 3.285

Review 4.  Orgasm and SCI: what do we know?

Authors:  Marcalee Alexander; Lesley Marson
Journal:  Spinal Cord       Date:  2017-12-20       Impact factor: 2.772

Review 5.  Management of priapism: an update for clinicians.

Authors:  Helen R Levey; Robert L Segal; Trinity J Bivalacqua
Journal:  Ther Adv Urol       Date:  2014-12

Review 6.  A benefit-risk assessment of baclofen in severe spinal spasticity.

Authors:  Alessandro Dario; Giustino Tomei
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

7.  Effects of intrathecal baclofen on perceived sexual functioning in men with spinal cord injury.

Authors:  Michael L Jones; Donald P Leslie; Gerald Bilsky; Brock Bowman
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

8.  Sexual dysfunction associated with intrathecal baclofen use: a report of two cases.

Authors:  April Saval; Anthony E Chiodo
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.